Skip to content

Investigation of the ketogenic effect of new product developments on the human organism

Investigation of the ketogenic effect of new product developments on the human organism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00034754
Enrollment
8
Registered
2024-08-07
Start date
2024-10-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy participants

Interventions

Group 1: New product developments (ketogenic breads) (intervention) Administration of a slice of bread (40 - 50 g) with a data collection time of 300 minutes (5 h) for each intervention. Group 2: Alt

Sponsors

Fachhochschule Münster
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: - BMI 18 - 25 - male, female (equal distribution) - no known metabolic disease (e.g. lipid metabolism disorder, diabetes mellitus type 1 or 2) - Not taking any medication (exception: contraceptives) - No chronic health impairment (e.g. cardiovascular diseases, thyroid defects, intestinal diseases) - No mental or language impairments - no low-carb, vegan or other diet with a permanent reduction in carbohydrate intake (DGE requirement: at least 50% carbohydrates) - Signature of the declaration of consent - Sufficient knowledge of the German language

Exclusion criteria

Exclusion criteria: - Taking dietary supplements with an effect on lipid metabolism (e.g. MCT) - Pregnancy/breastfeeding - Simultaneous participation in other studies/study programs - Taking medication (exception: contraceptives) - Allergies/intolerances to the intervention products/ingredients - No consent given for participation in the study - Underage or over the maximum age - presence of a serious illness or acute illness at the time of the study (e.g. diabetes mellitus) - Metabolic diseases that represent a contraindication for ketogenic meals

Design outcomes

Primary

MeasureTime frame
ß-hydroxybutyrate in capillary blood measured by sensor (SiBio, CKM System, Ketone Sensor) on the upper arm from time t0 to tmax

Secondary

MeasureTime frame
glucose in capillary blood, sensory parameters (taste, smell, feel, optics), side effects

Countries

Germany

Contacts

Public ContactTobias Fischer

Fachhochschule Münster

tobias.fischer@fh-muenster.de0251 83-65444

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026